Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial.

Autor: Klopp AH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Enserro D; Clinical Trials Development Division, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Powell M; Washington University School of Medicine, Obstetrics & Gynecology, St Louis, MO., Randall M; University of Kentucky, Radiation Oncology, Lexington, KY., Schink JC; Cancer Treatment Centers of America, City of Hope, Gynecologic Oncology, Chicago, IL., Mannel RS; University of Oklahoma Health Sciences, Oklahoma City, OK., Holman L; University of Oklahoma Health Sciences, Oklahoma City, OK., Bender D; University of Iowa Hospitals & Clinics, Iowa City, IA., Kushnir CL; Women's Cancer Center of Nevada, Las Vegas, NV., Backes F; The Ohio State University Wexner Medical Center and James Cancer Hospital, Columbus, OH., Zweizig SL; University of Massachusetts Memorial Health Care, Gynecologic Oncology, Worcester, MA., Waggoner S; Cleveland Clinic Foundation, Medical Oncology, Cleveland, OH., Bradley KA; University of Wisconsin Hospital and Clinics, Radiation Oncology, Madison, WI., Lawrence LD; Delaware/Christiana Care, Radiation Oncology, Newark, DE., Hanjani P; Abington Memorial Hospital, Gynecologic Oncology, Abington, PA., Darus CJ; Maine Medical Center, Gynecologic Oncology, Scarborough, ME.; Providence Gynecologic Oncology Program and Earle A Chiles Research Institute, Portland, OR., Small W Jr; Department of Radiation Oncology, Stritch School of Medicine, Loyola University Chicago, Cardinal Bernardin Cancer Center, Chicago, IL., Cardenes HR; New York-Presbyterian Hospital, Weill Cornell Medicine, Clinical Radiation Oncology, New York, NY., Feddock JM; Baptist Health, Radiation Oncology, Lexington, KY., Miller DS; University of Texas Southwestern Medical Center, Gynecologic Oncology, Dallas, TX.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jul 10; Vol. 42 (20), pp. 2425-2435. Date of Electronic Publication: 2024 Apr 25.

Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Autor: Fisher JG; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Tait D; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Garrett-Mayer E; American Society of Clinical Oncology, 2318 Mill Road, Alexandria, VA, 22314, USA., Halabi S; Duke University Medical Center, Durham, NC, USA., Mangat PK; American Society of Clinical Oncology, 2318 Mill Road, Alexandria, VA, 22314, USA. TAPURPublications@asco.org., Schink JC; Cancer Treatment Centers of America, Chicago, IL, USA., Alvarez RH; Cancer Treatment Centers of America, Atlanta, GA, USA., Veljovich D; Swedish Cancer Institute, Seattle, WA, USA., Cannon TL; Inova Schar Cancer Institute, Fairfax, VA, USA., Crilley PA; Cancer Treatment Centers of America, Philadelphia, PA, USA., Pollock T; Cancer Treatment Centers of America, Tulsa, OK, USA., Calfa CJ; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA., Al Baghdadi T; Michigan Cancer Research Consortium, Ypsilanti, MI, USA., Thota R; Intermountain Precision Genomics Cancer Clinic, Salt Lake City, UT, USA., Fleming N; The University of Texas MD Anderson Cancer Center, Sugarland, TX, USA., Cotta JA; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA., Rygiel AL; American Society of Clinical Oncology, 2318 Mill Road, Alexandria, VA, 22314, USA., Warren SL; American Society of Clinical Oncology, 2318 Mill Road, Alexandria, VA, 22314, USA., Schilsky RL; American Society of Clinical Oncology, 2318 Mill Road, Alexandria, VA, 22314, USA.

Publikováno v: Targeted oncology [Target Oncol] 2020 Dec; Vol. 15 (6), pp. 733-741.

Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.

Autor: Winder AD; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois., Maniar KP; Division of Surgical Pathology, Department of Pathology, Northwestern University, Chicago, Illinois., Wei JJ; Division of Surgical Pathology, Department of Pathology, Northwestern University, Chicago, Illinois., Liu D; Division of Biostatistics, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Scholtens DM; Division of Biostatistics, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Lurain JR; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois., Schink JC; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Spectrum Health, Grand Rapids, Michigan., Buttin BM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois., Filiaci VL; Statistics and Data Management Center, NRG Oncology, Buffalo, New York.; Roswell Park Cancer Institute, Buffalo, New York., Lankes HA; Statistics and Data Management Center, NRG Oncology, Buffalo, New York.; Roswell Park Cancer Institute, Buffalo, New York., Ramirez NC; Biopathology Center and Gynecologic Oncology Group Tissue Bank, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio., Park K; Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York., Singh M; Department of Pathology, University of Kansas School of Medicine and Medical Center, Kansas City, Kansas., Lieberman RW; Department of Obstetrics and Gynecology, University of Michigan Health System, Ann Arbor, Michigan.; Department of Pathology, University of Michigan Health System, Ann Arbor, Michigan., Mannel RS; Department of Gynecologic Oncology, The Peggy and Charles Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Powell MA; Division of Gynecologic Oncology, Washington University School of Medicine, St Louis, Missouri., Backes FJ; Division of Gynecologic Oncology, Ohio State University and James Comprehensive Cancer Center, Columbus, Ohio., Mathews CA; Division of Obstetrics and Gynecology, Women and Infants Hospital, Providence, Rhode Island., Pearl ML; Department of Obstetrics, Gynecology, and Reproductive Medicine, Stony Brook University Medical Center, Stony Brook, New York., Secord AA; Department of Obstetrics/Gynecology, Division of Gynecology Oncology, Duke University Medical Center, Durham, North Carolina., Peace DJ; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois., Mutch DG; Division of Gynecologic Oncology, Washington University School of Medicine, St Louis, Missouri., Creasman WT; Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, South Carolina., Kim JJ; Division of Reproductive Science in Medicine, Department of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois.

Publikováno v: Cancer [Cancer] 2017 Apr 01; Vol. 123 (7), pp. 1144-1155. Date of Electronic Publication: 2016 Dec 07.

Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia.

Autor: Osborne RJ; Sunnybrook Health Sciences Center, Toronto, Ontario, Canada; the NRG Oncology Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, New York; Spectrum Health Medical Group, Grand Rapids, Michigan; the University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma; the University of Colorado Cancer Center, Aurora, Colorado; New Britain General Hospital, Plainville, Connecticut; Women's Cancer Center, Las Vegas, Nevada; UCSF Helen Diller Comprehensive Cancer Center, San Francisco, California; Royal Hallamshire Hospital, Sheffield, United Kingdom; and the University of Texas Southwestern Medical Center, Dallas, Texas., Filiaci VL, Schink JC, Mannel RS, Behbakht K, Hoffman JS, Spirtos NM, Chan JK, Tidy JA, Miller DS

Publikováno v: Obstetrics and gynecology [Obstet Gynecol] 2016 Sep; Vol. 128 (3), pp. 535-542.

Barriers to prevention: knowledge of HPV, cervical cancer, and HPV vaccinations among African American women.

Autor: Strohl AE; Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL., Mendoza G; Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL., Ghant MS; Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL., Cameron KA; Division of General Internal Medicine and Geriatrics, Department of Medicine, and Center for Advancing Equity in Clinical Preventive Services, Feinberg School of Medicine, Northwestern University, Chicago, IL; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL., Simon MA; Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL., Schink JC; Department of Obstetrics and Gynecology, Spectrum Health Medical Group, Grand Rapids, MI., Marsh EE; Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL. Electronic address: erica-marsh@northwestern.edu.

Publikováno v: American journal of obstetrics and gynecology [Am J Obstet Gynecol] 2015 Jan; Vol. 212 (1), pp. 65.e1-5. Date of Electronic Publication: 2014 Jun 28.